Open Access
Open access
Nature Communications, volume 13, issue 1, publication number 155

A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo

Leo Hanke 1
Hrishikesh Das 2
Daniel J. Sheward 1, 3
Maria Laura A Perez Vidakovics 1
Egon Urgard 1
Ainhoa Moliner Morro 1
Changil Kim 1
Vivien Karl 1
Alec Pankow 1
Natalie L Smith 1
Bartlomiej Porebski 4
Oscar Fernandez Capetillo 4, 5
Erdinc Sezgin 6
Gabriel K. Pedersen 7
Jonathan M. Coquet 1
B. Martin Hallberg 2, 8
Ben Murrell 1
Gerald M. McInerney 1
Publication typeJournal Article
Publication date2022-01-10
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor16.6
ISSN20411723, 20411723
General Chemistry
General Biochemistry, Genetics and Molecular Biology
Multidisciplinary
General Physics and Astronomy
Abstract
Antibodies binding to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike have therapeutic promise, but emerging variants show the potential for virus escape. This emphasizes the need for therapeutic molecules with distinct and novel neutralization mechanisms. Here we describe the isolation of a nanobody that interacts simultaneously with two RBDs from different spike trimers of SARS-CoV-2, rapidly inducing the formation of spike trimer–dimers leading to the loss of their ability to attach to the host cell receptor, ACE2. We show that this nanobody potently neutralizes SARS-CoV-2, including the beta and delta variants, and cross-neutralizes SARS-CoV. Furthermore, we demonstrate the therapeutic potential of the nanobody against SARS-CoV-2 and the beta variant in a human ACE2 transgenic mouse model. This naturally elicited bispecific monomeric nanobody establishes an uncommon strategy for potent inactivation of viral antigens and represents a promising antiviral against emerging SARS-CoV-2 variants. Here, the authors isolate and characterize a bispecific monomeric nanobody that induces dimerization of SARS-CoV-2 spike trimers, neutralizes variants of concerns as well as SARS-CoV, and inhibits SARS-CoV-2 infection in mice.

Top-30

Citations by journals

1
2
3
Frontiers in Immunology
3 publications, 5.36%
Nano Letters
2 publications, 3.57%
International Journal of Molecular Sciences
2 publications, 3.57%
Cell Research
2 publications, 3.57%
Communications Biology
2 publications, 3.57%
Biotechnology Advances
2 publications, 3.57%
Nature Communications
2 publications, 3.57%
Journal of Virology
2 publications, 3.57%
Viruses
1 publication, 1.79%
Frontiers in Pharmacology
1 publication, 1.79%
Frontiers in Drug Discovery
1 publication, 1.79%
Frontiers in Nanotechnology
1 publication, 1.79%
Nature Chemical Biology
1 publication, 1.79%
Cell Discovery
1 publication, 1.79%
iScience
1 publication, 1.79%
International Journal of Biological Macromolecules
1 publication, 1.79%
Advanced Drug Delivery Reviews
1 publication, 1.79%
Molecular Diagnosis and Therapy
1 publication, 1.79%
ACS Applied Bio Materials
1 publication, 1.79%
Science advances
1 publication, 1.79%
Nature Biotechnology
1 publication, 1.79%
Science immunology
1 publication, 1.79%
Bioconjugate Chemistry
1 publication, 1.79%
Proceedings of the National Academy of Sciences of the United States of America
1 publication, 1.79%
Analytical Chemistry
1 publication, 1.79%
Exploration
1 publication, 1.79%
Analytica Chimica Acta
1 publication, 1.79%
Applied Microbiology
1 publication, 1.79%
Cell Insight
1 publication, 1.79%
1
2
3

Citations by publishers

2
4
6
8
10
12
Springer Nature
11 publications, 19.64%
Elsevier
9 publications, 16.07%
Frontiers Media S.A.
7 publications, 12.5%
Cold Spring Harbor Laboratory
7 publications, 12.5%
American Chemical Society (ACS)
6 publications, 10.71%
American Society for Microbiology
4 publications, 7.14%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 5.36%
American Association for the Advancement of Science (AAAS)
2 publications, 3.57%
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 1.79%
Wiley
1 publication, 1.79%
Acta Naturae Ltd
1 publication, 1.79%
Pleiades Publishing
1 publication, 1.79%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.79%
2
4
6
8
10
12
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Hanke L. et al. A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo // Nature Communications. 2022. Vol. 13. No. 1. 155
GOST all authors (up to 50) Copy
Hanke L., Das H., Sheward D. J., Perez Vidakovics M. L. A., Urgard E., Moliner Morro A., Kim C., Karl V., Pankow A., Smith N. L., Porebski B., Fernandez Capetillo O., Sezgin E., Pedersen G. K., Coquet J. M., Hallberg B. M., Murrell B., McInerney G. M. A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo // Nature Communications. 2022. Vol. 13. No. 1. 155
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41467-021-27610-z
UR - https://doi.org/10.1038/s41467-021-27610-z
TI - A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo
T2 - Nature Communications
AU - Hanke, Leo
AU - Das, Hrishikesh
AU - Sheward, Daniel J.
AU - Perez Vidakovics, Maria Laura A
AU - Urgard, Egon
AU - Moliner Morro, Ainhoa
AU - Kim, Changil
AU - Karl, Vivien
AU - Pankow, Alec
AU - Smith, Natalie L
AU - Porebski, Bartlomiej
AU - Fernandez Capetillo, Oscar
AU - Sezgin, Erdinc
AU - Pedersen, Gabriel K.
AU - Coquet, Jonathan M.
AU - Hallberg, B. Martin
AU - Murrell, Ben
AU - McInerney, Gerald M.
PY - 2022
DA - 2022/01/10 00:00:00
PB - Springer Nature
IS - 1
VL - 13
SN - 2041-1723
SN - 2041-1723
ER -
BibTex
Cite this
BibTex Copy
@article{2022_Hanke,
author = {Leo Hanke and Hrishikesh Das and Daniel J. Sheward and Maria Laura A Perez Vidakovics and Egon Urgard and Ainhoa Moliner Morro and Changil Kim and Vivien Karl and Alec Pankow and Natalie L Smith and Bartlomiej Porebski and Oscar Fernandez Capetillo and Erdinc Sezgin and Gabriel K. Pedersen and Jonathan M. Coquet and B. Martin Hallberg and Ben Murrell and Gerald M. McInerney},
title = {A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo},
journal = {Nature Communications},
year = {2022},
volume = {13},
publisher = {Springer Nature},
month = {jan},
url = {https://doi.org/10.1038/s41467-021-27610-z},
number = {1},
doi = {10.1038/s41467-021-27610-z}
}
Found error?